ArticleEMBO molecular medicine2022

A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis.

Lucía Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.